Zydus Lifesciences Launches Rexigo™, the Oral Once-a-Day Pill for Advanced Prostate Cancer Patients in India

Zydus Lifesciences Launches Rexigo™, the Oral Once-a-Day Pill for Advanced Prostate Cancer Patients in India

Ahmedabad, Gujarat, India – Business Wire India Rexigo™ (Relugolix) is a critical therapy as it suppresses testosterone in patients with advanced prostate cancer. Rexigo™ is the first generic, oral, once-a-day pill, making it much easier for patients. In the absence of this, patients needed to take injections. The drug’s better cardiovascular safety profile helps elderly … Read more